🔎 Trials Near Me

Inicio › Linfoma de Burkitt › Pensilvania › Philadelphia

Ensayos clínicos de Linfoma de Burkitt en Philadelphia, PA

16 estudios para Linfoma de Burkitt buscan participantes en centros de Philadelphia y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.

Texto oficial del estudio (inglés)

¿Reclutando participantes para un estudio? Destácalo en la parte superior de esta página — $99 por 30 días →

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

ReclutandoFase 3
  • Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
Edades de 1 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07223021

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

ReclutandoFase 1
  • Children's Hospital of Philadelphia, Philadelphia
Edades de 0 a 18 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06173518

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

ReclutandoFase 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · A 25 mi de distancia
366 Days – 46 Years · Todos los sexos · Actualizado el 2 oct 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

ReclutandoFase 3
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Edades de 18 a 39 · Todos los sexos · Actualizado el 2 oct 2026 · NCT03150693

Blinatumomab Consolidation in Real World

ReclutandoEstudio observacionalSe aceptan voluntarios sanos
  • University of Pennsylvania, Philadelphia
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

ReclutandoEstudio observacional
  • Children's Hospital of Philadelphia, Philadelphia
Edades de 0 a 38 · Todos los sexos · Actualizado el 1 oct 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

ReclutandoFase 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · A 25 mi de distancia
365 Days · Todos los sexos · Actualizado el 25 sept 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

ReclutandoFase 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Todos los sexos · Actualizado el 17 sept 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

ReclutandoFase 2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · A 25 mi de distancia
Edades de 1 a 30 · Todos los sexos · Actualizado el 1 sept 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

ReclutandoFase 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · A 25 mi de distancia
365 Days – 25 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

ReclutandoFase 2
  • Children's Hospital of Philadelphia, Philadelphia
Edades de 7 a 25 · Todos los sexos · Actualizado el 19 ago 2026 · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Reclutando
  • Children's Hospital of Philadelphia, Philadelphia
Hasta los 25 · Todos los sexos · Actualizado el 8 jul 2026 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

ReclutandoFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Edades de 0 a 29 · Todos los sexos · Actualizado el 26 may 2026 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

ReclutandoFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Hasta los 29 · Todos los sexos · Actualizado el 27 mar 2026 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

ReclutandoFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Edades de 15 a 50 · Todos los sexos · Actualizado el 9 sept 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

ReclutandoFase 2
  • Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · A 25 mi de distancia
Edades de 1 a 25 · Todos los sexos · Actualizado el 4 may 2025 · NCT03509961

Ensayos de Linfoma de Burkitt en otras ciudades

Otros estudios en Philadelphia

De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.